SNGX Stock: Soligenix Rockets on COVID-19 News

Soligenix SNGX Stock News

Soligenix, Inc. (NASDAQ: SNGX) is running up in the premarket hours this morning, and for good reason. The company announced positive preclinical data from a COVID-19 vaccine program.  Here’s what’s happening: Skip to What You Want to Read Soligenix Announces COVID-19 Vaccine News Management Commentary What Analysts Think About SNGX Stock Risks to Consider Before … Read more

Soligenix (SNGX) Stock: Rocketing On Late Stage Milestone Accomplishment

Soligenix SNGX Stock News

Soligenix, Inc. (NASDAQ: SNGX) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced that it has reached a key milestone with regard to a late-stage clinical development program. As you could imagine, the news excited investors, pushing the stock on a run for the top. … Read more

Soligenix (SNGX) Stock: Rocketing On Breakthrough Therapy Designation

Soligenix, Inc. (NASDAQ: SNGX) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced that it has been granted Orphan Drug Designation from the European Medicines Agency. Of course, this led to excitement among investors, sending the stock rocketing for the top. Today, we’ll talk about the … Read more

Soligenix (SNGX) Stock: Gains Big On Coming Presentation Of Clinical Results

Soligenix, Inc. Common Stock (NASDAQ: SNGX) is having an incredible day in the market today, and for good reason. The company announced the coming presentation of clinical data, exciting investors and leading to gains in the stock. Of course, our partners at Trade Ideas were the first to alert us to the movement. At the … Read more